Intracardiac Cardioversion for Atrial Fibrillation [Turk Kardiyol Dern Ars]
Turk Kardiyol Dern Ars. 1998; 26(2): 93-97

Intracardiac Cardioversion for Atrial Fibrillation

Barbaros DOKUMACI1, Sevda ATALAY1, Y. Ahmet ÜNALIR1, Necmi ATA1, Bilgin TİMURALP1

Cardioversion (CV) is the most effective therapeutic approach for reversion of atrial fibrillation (AF) to sinus rythm (SR). In addition to its being performed transthoracically, it may be performed via the intracardiac route. In this study we present the results of intracardiac cardioversion (ICC) in 29 patients. Mean age of the study group was 60±2 years and the mean AF duration was 36.9±7.2 months. We used Hewlett-Packard 43120A extemal defibrillator as the energy source for the first 15 patients, by means of a technique w e developed. For the remainder I 4, Yentak ECD cardioverter defibrillator was used. Reversion to SR was achieved in 72% of patients. Comparison of the success (n=2 I) and failure groups in regard to AF duration, left ventricular dimensions and ejection fraction revealed no statistical difference. Left atrial dimensions were significanıly higher in the failure group (pKeywords: Atrial fibrillation, intracardiac cardioversion


How to cite this article
Barbaros DOKUMACI, Sevda ATALAY, Y. Ahmet ÜNALIR, Necmi ATA, Bilgin TİMURALP. Intracardiac Cardioversion for Atrial Fibrillation. Turk Kardiyol Dern Ars. 1998; 26(2): 93-97
© Copyright 2020 Archives of the Turkish Society of Cardiology
LookUs & Online Makale